Fig. 5

Compared the incidence of the common adverse events (hypertension, hand-foot syndrome, and fatigue) between the ages of ≥ 70 years and < 70 years according to EGFR gene negative and mutation groups. A–C There was no statistical difference in the proportion of EGFR-negative patients who experienced the common adverse events at age ≥ 70 years and < 70 years. D–F There was also no statistical difference in the proportion of EGFR-mutation patients